ALX Oncology
ALXO
93 hedge funds and large institutions have $2.47B invested in ALX Oncology in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 17 reducing their positions, and 12 closing their positions.
340% more call options, than puts
Call options by funds: $3.96M | Put options by funds: $900K
176% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 17
33% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 12
4% more funds holding
Funds holding: 89 → 93 (+4)
1.73% more ownership
Funds ownership: 81.78% → 83.51% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
11% less capital invested
Capital invested by funds: $2.78B → $2.47B (-$311M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$53.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$42.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.3M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$24.3M |
| 5 |
AG
Artal Group
Luxembourg
|
+$17.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$73M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$46.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$20.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17.6M |
| 5 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$14.8M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFI
101
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| – | -$232K | -2,694 | Closed |
|
|
SAM
102
Shell Asset Management
The Hague,
Netherlands
| – | -$201K | -2,333 | Closed |
|
|
AA
103
AlphaCentric Advisors
San Juan,
Puerto Rico
| – | -$129K | -1,500 | Closed |
|
|
LC
104
Lindbrook Capital
Calabasas,
California
| – | -$60K | -700 | Closed |
|
105
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | +$236 | +3 | New |
|
ALXO Hedge Fund Activity: Q1 2021 in Review
93 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q1 2021, worth a combined $2.47B — down 11% from $2.78B a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ALXO positions and 12 closed out — a net gain of 4 holders — while 47 added to existing stakes and 17 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $53.4M. The largest seller was Board of Trustees of The Leland Stanford Junior University, cutting an estimated $73M.
- 93 institutional investors held ALX Oncology (ALXO) as of Q1 2021, up from 89 in Q4 2020.
- Funds reported $2.47B of ALX Oncology stock for Q1 2021, down 11% quarter-over-quarter.
- 16 funds opened new ALX Oncology positions in Q1 2021 and 12 closed out, a net change of +4 holders.
- The largest ALX Oncology buyer in Q1 2021 was Wellington Management Group, an estimated $53.4M added.
- The largest ALX Oncology seller in Q1 2021 was Board of Trustees of The Leland Stanford Junior University, an estimated $73M sold.
Based on aggregated 13F filings for Q1 2021.